By Davit Kirakosyan
Citi downgraded Varonis Systems (NASDAQ:) to Neutral from Buy with a price target of $21.00. Shares plunged more than 35% intra-day today following the company’s reported Q3 miss.
William Blair downgraded ABIOMED Inc (NASDAQ:) to Market Perform from Outperform. Shares surged nearly 50% intra-day today after Johnson & Johnson (NYSE:) announced it had entered into a definitive agreement to acquire through a tender offer all outstanding shares of ABIOMED, for an upfront payment of $380.00 per share in cash, corresponding to an enterprise value of approximately $16.6 billion.
KeyBanc downgraded Avista (NYSE:) to Underweight from Sector Weight with a price target of $33.00 following the company’s reported below-consensus Q3 results and lowered guidance for 2022 and 2023. Shares were down more than 8% intra-day today.
Wedbush analysts downgraded Steven Madden (NASDAQ:) to Neutral from Outperform and lowered its price target to $29.00 from $43.00.
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
Story Credit: investing.com